NYSE · Healthcare
Danaher Corporation (DHR) stock research
Danaher Corporation (DHR) is listed on NYSE. Danaher Corporation reported revenue of $24.6B in the fiscal year that ended on 2025-12-31. Revenue rose 2.9% from the year before. Danaher Corporation’s net income for that year was $3.6B. The SEC classifies it under Industrial Instruments For Measurement, Display, and Control. It is incorporated in Delaware. Its most recent SEC filing is Form 8-K (current report), filed on 2026-10-13.
Open DHR in Willow. Filings, fundamentals, recent news — sourced stock research, no recommendation.
Annual financials
As tagged by Danaher Corporation in its annual reports on SEC EDGAR. The latest year is from Form 10-K, filed on 2026-02-24.
| Fiscal year ended | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2025-12-31 | $24.6B | $3.6B | $5.05 |
| 2024-12-31 | $23.9B | $3.9B | $5.29 |
| 2023-12-31 | $23.9B | $4.8B | $6.38 |
Recent SEC filings
Filed with the SEC under CIK 0000313616. Every row is read from the filing itself on EDGAR, not from a summary of it.
- 8-K (current report) filed 2026-10-13 · period ending 2026-10-09
- 8-K (current report) filed 2026-08-03 · period ending 2026-07-31
- 8-K (current report) filed 2026-07-21 · period ending 2026-07-21
- 10-Q (quarterly report) filed 2026-07-21 · period ending 2026-06-26
- 8-K (current report) filed 2026-06-03 · period ending 2026-06-03
- 8-K (current report) filed 2026-05-07 · period ending 2026-05-05
Filing history read from SEC EDGAR on 2026-10-19.
What a Willow brief on DHR checks
- Recent filings and company disclosures.
- TTM fundamentals and valuation context.
- Recent news and market context separated from primary filings.
- Bull case, bear case, key risks, and watch-next items in a non-directional register.
Questions about DHR
- What was Danaher Corporation’s revenue in the fiscal year ended 2025-12-31?
- $24.6B for the fiscal year that ended on 2025-12-31, as reported in Form 10-K filed on 2026-02-24.
- Was Danaher Corporation profitable in the fiscal year ended 2025-12-31?
- Yes. It reported net income of $3.6B for the fiscal year that ended on 2025-12-31.
- What were Danaher Corporation’s diluted earnings per share in the fiscal year ended 2025-12-31?
- $5.05 per diluted share for the fiscal year that ended on 2025-12-31.
- What is Danaher Corporation’s most recent SEC filing?
- Form 8-K (current report), filed on 2026-10-13. brief.finance reads it directly from SEC EDGAR.
- When does Danaher Corporation’s fiscal year end?
- Its SEC registration lists the year end as 31 December. The annual figures on this page cover the fiscal year that ended on 2025-12-31.
- What is Danaher Corporation’s SEC CIK number?
- 0000313616. EDGAR uses this Central Index Key to identify every filing the company submits.
- What does a Willow brief on DHR include?
- Recent SEC filings, fundamentals and valuation context, price history, and both a bull case and a bear case. Every figure links to the source it came from.
- Does brief.finance say whether to buy or sell DHR?
- No. brief.finance publishes educational research and does not recommend buying, selling, or holding any security.
Primary source paths
- SEC EDGAR company filings search
- Nasdaq market activity page
- brief.finance methodology and source checks
More Healthcare research hubs
- ABBV — AbbVie Inc.
- ABT — Abbott Laboratories
- AMGN — Amgen Inc.
- BIIB — Biogen Inc.
- BMY — Bristol-Myers Squibb Company
- CI — The Cigna Group
- CVS — CVS Health Corporation
- ELV — Elevance Health, Inc.
- Browse all Healthcare research hubs
Author and editorial responsibility
By Joseph, Founder and editor, brief.finance. Every brief is generated under a fixed editorial and compliance method operated by Reaktif LLC.
About the author · Disclosures · Stock Directory
Ticker catalog last updated 2026-10-19.